{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:02:04Z","timestamp":1789646524879,"version":"4.0.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"State Key Laboratory of Neurology and Oncology Drug Development","award":["SKLSIM-F-2025282"],"award-info":[{"award-number":["SKLSIM-F-2025282"]}]},{"name":"Foundation of State Key Laboratory of Ultrasound in Medicine and Engineering","award":["2021KFKT010"],"award-info":[{"award-number":["2021KFKT010"]}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0770"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0770"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program","award":["2023YFQ0057"],"award-info":[{"award-number":["2023YFQ0057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11136-026-04338-1","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:27:20Z","timestamp":1784824040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation and cutpoints of the treatment-induced neuropathy assessment scale (TNAS) in Chinese cancer patients: a prospective cohort study"],"prefix":"10.1007","volume":"35","author":[{"given":"Chenxi","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0660-3809","authenticated-orcid":false,"given":"Qiuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"1","key":"4338_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-020-0180-8","volume":"4","author":"TR Mendoza","year":"2020","unstructured":"Mendoza, T. R., Williams, L. A., Shi, Q., Wang, X. S., Bamidele, O., Woodruff, J. F., & Cleeland, C. S. (2020). The treatment-induced neuropathy assessment scale (TNAS): A psychometric update following qualitative enrichment. Journal of Patient-Reported Outcomes, 4(1), Article 15. https:\/\/doi.org\/10.1186\/s41687-020-0180-8","journal-title":"Journal of Patient-Reported Outcomes"},{"issue":"10","key":"4338_CR2","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jpain.2015.07.002","volume":"16","author":"TR Mendoza","year":"2015","unstructured":"Mendoza, T. R., Wang, X. S., Williams, L. A., Shi, Q., Vichaya, E. G., Dougherty, P. M., Thomas, S. K., Yucel, E., Bastida, C. C., Woodruff, J. F., & Cleeland, C. S. (2015). Measuring therapy-induced peripheral neuropathy: Preliminary development and validation of the treatment-induced neuropathy assessment scale. The Journal of Pain, 16(10), 1032\u20131043. https:\/\/doi.org\/10.1016\/j.jpain.2015.07.002","journal-title":"The Journal of Pain"},{"issue":"28","key":"4338_CR3","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.20.01399","volume":"38","author":"CL Loprinzi","year":"2020","unstructured":"Loprinzi, C. L., Lacchetti, C., Bleeker, J., Cavaletti, G., Chauhan, C., Hertz, D. L., Kelley, M. R., Lavino, A., Lustberg, M. B., Paice, J. A., Schneider, B. P., Lavoie Smith, E. M., Smith, M. L., Smith, T. J., Wagner-Johnston, N., & Hershman, D. L. (2020). Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 38(28), 3325\u20133348. https:\/\/doi.org\/10.1200\/JCO.20.01399","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"2","key":"4338_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","volume":"9","author":"J Burgess","year":"2021","unstructured":"Burgess, J., Ferdousi, M., Gosal, D., Boon, C., Matsumoto, K., Marshall, A., Mak, T., Marshall, A., Frank, B., Malik, R. A., & Alam, U. (2021). Chemotherapy-induced peripheral neuropathy: Epidemiology, pathomechanisms and treatment. Oncology and Therapy, 9(2), 385\u2013450. https:\/\/doi.org\/10.1007\/s40487-021-00168-y","journal-title":"Oncology and Therapy"},{"issue":"30","key":"4338_CR5","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1200\/JCO.2014.58.8533","volume":"33","author":"DR Pachman","year":"2015","unstructured":"Pachman, D. R., Qin, R., Seisler, D. K., Smith, E. M., Beutler, A. S., Ta, L. E., Lafky, J. M., Wagner-Johnston, N. D., Ruddy, K. J., Dakhil, S., Staff, N. P., Grothey, A., & Loprinzi, C. L. (2015). Clinical course of oxaliplatin-induced neuropathy: Results from the randomized phase III trial N08CB (Alliance). Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 33(30), 3416\u20133422. https:\/\/doi.org\/10.1200\/JCO.2014.58.8533","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"10","key":"4338_CR6","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.12998\/wjcc.v10.i10.3101","volume":"10","author":"I Prutianu","year":"2022","unstructured":"Prutianu, I., Alexa-Stratulat, T., Cristea, E. O., Nicolau, A., Moisuc, D. C., Covrig, A. A., Ivanov, K., Croitoru, A. E., Miron, M. I., Dinu, M. I., Ivanov, A. V., Marinca, M. V., Radu, I., & Gafton, B. (2022). Oxaliplatin-induced neuropathy and colo-rectal cancer patient\u2019s quality of life: Practical lessons from a prospective cross-sectional, real-world study. World Journal of Clinical Cases, 10(10), 3101\u20133112. https:\/\/doi.org\/10.12998\/wjcc.v10.i10.3101","journal-title":"World Journal of Clinical Cases"},{"issue":"14","key":"4338_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16142571","volume":"16","author":"KT Lee","year":"2024","unstructured":"Lee, K. T., Bulls, H. W., Hoogland, A. I., James, B. W., Colon-Echevarria, C. B., & Jim, H. S. L. (2024). Chemotherapy-induced peripheral neuropathy (CIPN): A narrative review and proposed theoretical model. Cancers, 16(14), Article 2571. https:\/\/doi.org\/10.3390\/cancers16142571","journal-title":"Cancers"},{"issue":"8","key":"4338_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/life14080991","volume":"14","author":"M Mattar","year":"2024","unstructured":"Mattar, M., Umutoni, F., Hassan, M. A., Wamburu, M. W., Turner, R., Patton, J. S., Chen, X., & Lei, W. (2024). Chemotherapy-induced peripheral neuropathy: A recent update on pathophysiology and treatment. Life (Basel, Switzerland), 14(8), 991. https:\/\/doi.org\/10.3390\/life14080991","journal-title":"Life (Basel, Switzerland)"},{"issue":"21","key":"4338_CR9","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1200\/JCO.2013.49.1514","volume":"31","author":"F Mols","year":"2013","unstructured":"Mols, F., Beijers, T., Lemmens, V., van den Hurk, C. J., Vreugdenhil, G., & van de Poll-Franse, L. V. (2013). Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: Results from the population-based PROFILES registry. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 31(21), 2699\u20132707. https:\/\/doi.org\/10.1200\/JCO.2013.49.1514","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"1","key":"4338_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.annonc.2019.09.006","volume":"31","author":"AJM Beijers","year":"2020","unstructured":"Beijers, A. J. M., Bonhof, C. S., Mols, F., Ophorst, J., de Vos-Geelen, J., Jacobs, E. M. G., van de Poll-Franse, L. V., & Vreugdenhil, G. (2020). Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 31(1), 131\u2013136. https:\/\/doi.org\/10.1016\/j.annonc.2019.09.006","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology"},{"issue":"7","key":"4338_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1001\/jamaneurol.2016.0383","volume":"73","author":"NA Kolb","year":"2016","unstructured":"Kolb, N. A., Smith, A. G., Singleton, J. R., Beck, S. L., Stoddard, G. J., Brown, S., & Mooney, K. (2016). The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling. JAMA Neurology, 73(7), 860\u2013866. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0383","journal-title":"JAMA Neurology"},{"issue":"2","key":"4338_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09190-6","volume":"33","author":"DL Hertz","year":"2025","unstructured":"Hertz, D. L., Tanay, M., Tofthagen, C., Rossi, E., Bernasconi, D. P., Sheffield, K. E., Carlson, M., Nekhlyudov, L., Grech, L., Von Ah, D., Mayo, S. J., Ruddy, K. J., Chan, A., Alberti, P., & Lustberg, M. B. (2025). Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy. Supportive Care in Cancer\u202f: Official Journal of the Multinational Association of Supportive Care in Cancer, 33(2), Article 142. https:\/\/doi.org\/10.1007\/s00520-025-09190-6","journal-title":"Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"8","key":"4338_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.26463","volume":"6","author":"A Cao","year":"2023","unstructured":"Cao, A., Cartmel, B., Li, F. Y., Gottlieb, L. T., Harrigan, M., Ligibel, J. A., Gogoi, R., Schwartz, P. E., Esserman, D. A., Irwin, M. L., & Ferrucci, L. M. (2023). Effect of exercise on chemotherapy-induced peripheral neuropathy among patients treated for ovarian cancer: A secondary analysis of a randomized clinical trial. JAMA Network Open, 6(8), Article e2326463. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.26463","journal-title":"JAMA Network Open"},{"key":"4338_CR14","doi-asserted-by":"publisher","unstructured":"Teng, C., Venkatesha, Blinman, P. L., & Vardy, J. L. (2022). Patterns of Patient-Reported Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Survivors. Journal of the National Comprehensive Cancer Network : JNCCN, 20(12), 1308\u20131315. https:\/\/doi.org\/10.6004\/jnccn.2022.7050","DOI":"10.6004\/jnccn.2022.7050"},{"issue":"3","key":"4338_CR15","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.1188\/10.CJON.E22-E28","volume":"14","author":"C Tofthagen","year":"2010","unstructured":"Tofthagen, C. (2010). Patient perceptions associated with chemotherapy-induced peripheral neuropathy. Clinical Journal of Oncology Nursing, 14(3), E22\u2013E28. https:\/\/doi.org\/10.1188\/10.CJON.E22-E28","journal-title":"Clinical Journal of Oncology Nursing"},{"issue":"4","key":"4338_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/0284186X.2018.1556804","volume":"58","author":"LM Soveri","year":"2019","unstructured":"Soveri, L. M., Lamminm\u00e4ki, A., H\u00e4nninen, U. A., Karhunen, M., Bono, P., & Osterlund, P. (2019). Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy. Acta Oncologica (Stockholm, Sweden), 58(4), 398\u2013406. https:\/\/doi.org\/10.1080\/0284186X.2018.1556804","journal-title":"Acta Oncologica (Stockholm, Sweden)"},{"issue":"3","key":"4338_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10549-022-06670-9","volume":"195","author":"K Engvall","year":"2022","unstructured":"Engvall, K., Gr\u00e9en, H., Fredrikson, M., Lagerlund, M., Lewin, F., & \u00c5vall-Lundqvist, E. (2022). Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: A population-based cross-sectional study. Breast Cancer Research and Treatment, 195(3), 379\u2013391. https:\/\/doi.org\/10.1007\/s10549-022-06670-9","journal-title":"Breast Cancer Research and Treatment"},{"key":"4338_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1005083","volume":"12","author":"L Schwab","year":"2023","unstructured":"Schwab, L., & Visovsky, C. (2023). Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review. Frontiers in Oncology, 12, Article 1005083. https:\/\/doi.org\/10.3389\/fonc.2022.1005083","journal-title":"Frontiers in Oncology"},{"key":"4338_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102241","volume":"99","author":"DL Hertz","year":"2021","unstructured":"Hertz, D. L., Childs, D. S., Park, S. B., Faithfull, S., Ke, Y., Ali, N. T., McGlown, S. M., Chan, A., Grech, L. B., Loprinzi, C. L., Ruddy, K. J., & Lustberg, M. (2021). Patient-centric decision framework for treatment alterations in patients with chemotherapy-induced peripheral neuropathy (CIPN). Cancer Treatment Reviews, 99, Article 102241. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102241","journal-title":"Cancer Treatment Reviews"},{"issue":"22","key":"4338_CR20","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1002\/cam4.4328","volume":"10","author":"MR Trendowski","year":"2021","unstructured":"Trendowski, M. R., Lusk, C. M., Ruterbusch, J. J., Seaton, R., Simon, M. S., Greenwald, M. K., Harper, F. W. K., Beebe-Dimmer, J. L., & Schwartz, A. G. (2021). Chemotherapy-induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes. Cancer Medicine, 10(22), 8151\u20138161. https:\/\/doi.org\/10.1002\/cam4.4328","journal-title":"Cancer Medicine"},{"key":"4338_CR21","doi-asserted-by":"publisher","unstructured":"Jordan, B., Margulies, A., Cardoso, F., Cavaletti, G., Haugnes, H. S., Jahn, P., Le Rhun, E., Preusser, M., Scott\u00e9, F., Taphoorn, M. J. B., Jordan, K., ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org, EONS Education Working Group. Electronic address: eons.secretariat@cancernurse.eu, & EANO Guideline Committee. Electronic address: office@eano.eu (2020). Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology, 31(10), 1306\u20131319. https:\/\/doi.org\/10.1016\/j.annonc.2020.07.003.","DOI":"10.1016\/j.annonc.2020.07.003"},{"issue":"1","key":"4338_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaf119","volume":"10","author":"K Chen","year":"2026","unstructured":"Chen, K., Antonen, E., Nadler, M. B., Mauti, E., & Jones, J. M. (2026). Assessment tools for chemotherapy-induced peripheral neuropathy: A narrative review of clinician, patient-reported, and objective measures. JNCI Cancer Spectrum, 10(1), Article pkaf119. https:\/\/doi.org\/10.1093\/jncics\/pkaf119","journal-title":"JNCI Cancer Spectrum"},{"key":"4338_CR23","doi-asserted-by":"publisher","unstructured":"Alberti, P., Rossi, E., Cornblath, D. R., Merkies, I. S., Postma, T. J., Frigeni, B., Bruna, J., Velasco, R., Argyriou, A. A., Kalofonos, H. P., Psimaras, D., Ricard, D., Pace, A., Gali\u00e8, E., Briani, C., Dalla Torre, C., Faber, C. G., Lalisang, R. I., Boogerd, W., Brandsma, D., CI-PeriNomS Group (2014). Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Annals of oncology: official journal of the European Society for Medical Oncology, 25(1), 257\u2013264. https:\/\/doi.org\/10.1093\/annonc\/mdt409","DOI":"10.1093\/annonc\/mdt409"},{"issue":"11","key":"4338_CR24","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/annonc\/mdx491","volume":"28","author":"SB Park","year":"2017","unstructured":"Park, S. B., Kwok, J. B., Asher, R., Lee, C. K., Beale, P., Selle, F., & Friedlander, M. (2017). Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial. Annals of oncology: Official journal of the European Society for Medical Oncology, 28(11), 2733\u20132740. https:\/\/doi.org\/10.1093\/annonc\/mdx491","journal-title":"Annals of oncology: Official journal of the European Society for Medical Oncology"},{"issue":"3","key":"4338_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti, A., Colevas, A. D., Setser, A., Rusch, V., Jaques, D., Budach, V., Langer, C., Murphy, B., Cumberlin, R., Coleman, C. N., & Rubin, P. (2003). CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Seminars in Radiation Oncology, 13(3), 176\u2013181. https:\/\/doi.org\/10.1016\/S1053-4296(03)00031-6","journal-title":"Seminars in Radiation Oncology"},{"issue":"3","key":"4338_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ejca.2009.12.008","volume":"46","author":"G Cavaletti","year":"2010","unstructured":"Cavaletti, G., Frigeni, B., Lanzani, F., Mattavelli, L., Susani, E., Alberti, P., Cortinovis, D., & Bidoli, P. (2010). Chemotherapy-induced peripheral neurotoxicity assessment: A critical revision of the currently available tools. European Journal of Cancer, 46(3), 479\u2013494. https:\/\/doi.org\/10.1016\/j.ejca.2009.12.008","journal-title":"European Journal of Cancer"},{"issue":"5","key":"4338_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrclinonc.2015.222","volume":"13","author":"M Di Maio","year":"2016","unstructured":"Di Maio, M., Basch, E., Bryce, J., & Perrone, F. (2016). Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. Nature Reviews. Clinical Oncology, 13(5), 319\u2013325. https:\/\/doi.org\/10.1038\/nrclinonc.2015.222","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"2","key":"4338_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.6004\/jnccn.2022.7074","volume":"21","author":"T Li","year":"2023","unstructured":"Li, T., Timmins, H. C., Trinh, T., Mizrahi, D., Harrison, M., Horvath, L. G., Grimison, P., Friedlander, M., Kiernan, M. C., King, M. T., Rutherford, C., Goldstein, D., & Park, S. B. (2023). Patient-reported outcome measures in chemotherapy-induced peripheral neurotoxicity: Defining minimal and clinically important changes. Journal of the National Comprehensive Cancer Network: JNCCN, 21(2), 125-132.e3. https:\/\/doi.org\/10.6004\/jnccn.2022.7074","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"issue":"11","key":"4338_CR29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","volume":"7","author":"E Basch","year":"2006","unstructured":"Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006). Patient versus clinician symptom reporting using the national cancer institute common terminology criteria for adverse events: Results of a questionnaire-based study. The Lancet. Oncology, 7(11), 903\u2013909. https:\/\/doi.org\/10.1016\/S1470-2045(06)70910-X","journal-title":"The Lancet. Oncology"},{"issue":"8","key":"4338_CR30","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.ejca.2005.02.012","volume":"41","author":"TJ Postma","year":"2005","unstructured":"Postma, T. J., Aaronson, N. K., Heimans, J. J., Muller, M. J., Hildebrand, J. G., Delattre, J. Y., Hoang-Xuan, K., Lant\u00e9ri-Minet, M., Grant, R., Huddart, R., Moynihan, C., Maher, J., Lucey, R., EORTC Quality of Life Group. (2005). The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20. European Journal of Cancer, 41(8), 1135\u20131139. https:\/\/doi.org\/10.1016\/j.ejca.2005.02.012","journal-title":"European Journal of Cancer"},{"issue":"6","key":"4338_CR31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1525-1438.2003.13603.x","volume":"13","author":"EA Calhoun","year":"2003","unstructured":"Calhoun, E. A., Welshman, E. E., Chang, C. H., Lurain, J. R., Fishman, D. A., Hunt, T. L., & Cella, D. (2003). Psychometric evaluation of the functional assessment of cancer therapy\/gynecologic oncology group-neurotoxicity (Fact\/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 13(6), 741\u2013748. https:\/\/doi.org\/10.1111\/j.1525-1438.2003.13603.x","journal-title":"International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society"},{"issue":"7","key":"4338_CR32","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","volume":"22","author":"MF Janssen","year":"2013","unstructured":"Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., Swinburn, P., & Busschbach, J. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 22(7), 1717\u20131727. https:\/\/doi.org\/10.1007\/s11136-012-0322-4","journal-title":"Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation"},{"issue":"3","key":"4338_CR33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00520-018-4391-y","volume":"27","author":"LA Williams","year":"2019","unstructured":"Williams, L. A., Garcia-Gonzalez, A., Mendoza, T. R., Haq, S., & Cleeland, C. S. (2019). Concept domain validation and item generation for the treatment-induced neuropathy assessment Scale (TNAS). Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 27(3), 1021\u20131028. https:\/\/doi.org\/10.1007\/s00520-018-4391-y","journal-title":"Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"1","key":"4338_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-96978-5","volume":"15","author":"Y Jin","year":"2025","unstructured":"Jin, Y., Li, Y., Xiong, L., Tang, C., & Ma, H. (2025). Psychometric properties and longitudinal measurement invariance of the treatment-induced neuropathy assessment scale in the Chinese cancer chemotherapy population. Scientific Reports, 15(1), Article 11960. https:\/\/doi.org\/10.1038\/s41598-025-96978-5","journal-title":"Scientific Reports"},{"issue":"Suppl 5 Suppl 1","key":"4338_CR35","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1097\/MLR.0000000000001062","volume":"57","author":"Q Shi","year":"2019","unstructured":"Shi, Q., Mendoza, T. R., & Cleeland, C. S. (2019). Interpreting patient-reported outcome scores for clinical research and practice: Definition, determination, and application of cutpoints. Medical Care, 57(Suppl 5 Suppl 1), S8\u2013S12. https:\/\/doi.org\/10.1097\/MLR.0000000000001062","journal-title":"Medical Care"},{"issue":"7","key":"4338_CR36","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jclinepi.2008.09.012","volume":"62","author":"F Tubach","year":"2009","unstructured":"Tubach, F., Giraudeau, B., & Ravaud, P. (2009). The variability in minimal clinically important difference and patient acceptable symptomatic state values did not have an impact on treatment effect estimates. Journal of Clinical Epidemiology, 62(7), 725\u2013728. https:\/\/doi.org\/10.1016\/j.jclinepi.2008.09.012","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"4338_CR37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","volume":"10","author":"R Jaeschke","year":"1989","unstructured":"Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10(4), 407\u2013415. https:\/\/doi.org\/10.1016\/0197-2456(89)90005-6","journal-title":"Controlled Clinical Trials"},{"key":"4338_CR38","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2147\/PPA.S348633","volume":"16","author":"Q Yu","year":"2022","unstructured":"Yu, Q., Yu, H., Xu, W., Pu, Y., Nie, Y., Dai, W., Wei, X., Wang, X. S., Cleeland, C. S., Li, Q., & Shi, Q. (2022). Shortness of breath on day 1 after surgery alerting the presence of early respiratory complications after surgery in lung cancer patients. Patient Preference and Adherence, 16, 709\u2013722. https:\/\/doi.org\/10.2147\/PPA.S348633","journal-title":"Patient Preference and Adherence"},{"issue":"2","key":"4338_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","volume":"318","author":"E Basch","year":"2017","unstructured":"Basch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA, 318(2), 197\u2013198. https:\/\/doi.org\/10.1001\/jama.2017.7156","journal-title":"JAMA"},{"issue":"9","key":"4338_CR40","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1200\/JCO.21.01344","volume":"40","author":"W Dai","year":"2022","unstructured":"Dai, W., Feng, W., Zhang, Y., Wang, X. S., Liu, Y., Pompili, C., Xu, W., Xie, S., Wang, Y., Liao, J., Wei, X., Xiang, R., Hu, B., Tian, B., Yang, X., Wang, X., Xiao, P., Lai, Q., Wang, X., \u2026 Shi, Q. (2022). Patient-reported outcome-based symptom management versus usual care after lung cancer surgery: A multicenter randomized controlled trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 40(9), 988\u2013996. https:\/\/doi.org\/10.1200\/JCO.21.01344","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"18","key":"4338_CR41","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1200\/JCO.23.01854","volume":"42","author":"W Dai","year":"2024","unstructured":"Dai, W., Wang, Y., Liao, J., Wei, X., Dai, Z., Xu, W., Liu, Y., Wang, X. S., Pompili, C., Yu, H., Pu, Y., Zhao, Y., Cao, B., Wang, Q., Feng, W., Zhang, Y., Liu, F., Deng, Y., Zhou, J., \u2026 Shi, Q. (2024). Electronic Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 42(18), 2126\u20132131. https:\/\/doi.org\/10.1200\/JCO.23.01854","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"issue":"4","key":"4338_CR42","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jpainsymman.2019.01.007","volume":"57","author":"RW Chen","year":"2019","unstructured":"Chen, R. W., Yang, S. L., Xu, Z. Y., Peng, M., Chen, M. N., Wang, Q. S., Chang, J., & Hu, J. L. (2019). Validation and application of the Chinese version of the M. D. Anderson symptom inventory gastrointestinal cancer module (MDASI-GI-C). Journal of Pain and Symptom Management, 57(4), 820\u2013827. https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.01.007","journal-title":"Journal of Pain and Symptom Management"},{"issue":"8","key":"4338_CR43","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/cncr.24920","volume":"116","author":"XS Wang","year":"2010","unstructured":"Wang, X. S., Williams, L. A., Eng, C., Mendoza, T. R., Shah, N. A., Kirkendoll, K. J., Shah, P. K., Trask, P. C., Palos, G. R., & Cleeland, C. S. (2010). Validation and application of a module of the M. D. Anderson symptom inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer, 116(8), 2053\u20132063. https:\/\/doi.org\/10.1002\/cncr.24920","journal-title":"Cancer"},{"issue":"9","key":"4338_CR44","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1245\/s10434-022-11629-7","volume":"29","author":"W Xu","year":"2022","unstructured":"Xu, W., Dai, W., Gao, Z., Wang, X. S., Tang, L., Pu, Y., Yu, Q., Yu, H., Nie, Y., Zhuang, W., Qiao, G., Cleeland, C. S., & Shi, Q. (2022). Establishment of minimal clinically important improvement for patient-reported symptoms to define recovery after video-assisted thoracoscopic surgery. Annals of Surgical Oncology, 29(9), 5593\u20135604. https:\/\/doi.org\/10.1245\/s10434-022-11629-7","journal-title":"Annals of Surgical Oncology"},{"key":"4338_CR45","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Published November 27, 2017. Accessed [1 Apr 2024]. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm."},{"issue":"6","key":"4338_CR46","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1097\/j.pain.0000000000000890","volume":"158","author":"Q Shi","year":"2017","unstructured":"Shi, Q., Mendoza, T. R., Dueck, A. C., Ma, H., Zhang, J., Qian, Y., Bhowmik, D., & Cleeland, C. S. (2017). Determination of mild, moderate, and severe pain interference in patients with cancer. Pain, 158(6), 1108\u20131112. https:\/\/doi.org\/10.1097\/j.pain.0000000000000890","journal-title":"Pain"},{"issue":"1","key":"4338_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-022-02003-y","volume":"20","author":"S Xie","year":"2022","unstructured":"Xie, S., Wang, D., Wu, J., Liu, C., & Jiang, W. (2022). Comparison of the measurement properties of SF-6Dv2 and EQ-5D-5L in a Chinese population health survey. Health and Quality of Life Outcomes, 20(1), Article 96. https:\/\/doi.org\/10.1186\/s12955-022-02003-y","journal-title":"Health and Quality of Life Outcomes"},{"issue":"5","key":"4338_CR48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s0895-4356(99)00206-1","volume":"53","author":"JA Husted","year":"2000","unstructured":"Husted, J. A., Cook, R. J., Farewell, V. T., & Gladman, D. D. (2000). Methods for assessing responsiveness: A critical review and recommendations. Journal of Clinical Epidemiology, 53(5), 459\u2013468. https:\/\/doi.org\/10.1016\/s0895-4356(99)00206-1","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"4338_CR49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","volume":"61","author":"D Revicki","year":"2008","unstructured":"Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61(2), 102\u2013109. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.03.012","journal-title":"Journal of Clinical Epidemiology"},{"key":"4338_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/15347354231185110","volume":"22","author":"K Suzuki","year":"2023","unstructured":"Suzuki, K., Morishita, S., Nakano, J., Okayama, T., Inoue, J., Tanaka, T., & Fukushima, T. (2023). Neurological outcomes of chemotherapy-induced peripheral neuropathy in patients with cancer: A systematic review and meta-analysis. Integrative Cancer Therapies, 22, Article 15347354231185110. https:\/\/doi.org\/10.1177\/15347354231185110","journal-title":"Integrative Cancer Therapies"},{"issue":"3","key":"4338_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/cncr.28434","volume":"120","author":"XS Wang","year":"2014","unstructured":"Wang, X. S., Zhao, F., Fisch, M. J., O\u2019Mara, A. M., Cella, D., Mendoza, T. R., & Cleeland, C. S. (2014). Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors. Cancer, 120(3), 425\u2013432. https:\/\/doi.org\/10.1002\/cncr.28434","journal-title":"Cancer"},{"issue":"9","key":"4338_CR52","doi-asserted-by":"publisher","first-page":"7705","DOI":"10.1007\/s00520-022-07197-x","volume":"30","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Su, X., Xu, W., Yu, Q., Dai, W., Wang, Y., Zhuang, X., Li, Q., Wang, X. S., & Shi, Q. (2022). Identifying patients who suffered from post-discharge cough after lung cancer surgery. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 30(9), 7705\u20137713. https:\/\/doi.org\/10.1007\/s00520-022-07197-x","journal-title":"Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer"},{"issue":"1","key":"4338_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/(sici)1097-0258(20000115)19:1<113::aid-sim245>3.0.co;2-o","volume":"19","author":"M Mazumdar","year":"2000","unstructured":"Mazumdar, M., & Glassman, J. R. (2000). Categorizing a prognostic variable: Review of methods, code for easy implementation and applications to decision-making about cancer treatments. Statistics in medicine, 19(1), 113\u2013132. https:\/\/doi.org\/10.1002\/(sici)1097-0258(20000115)19:1%3c113::aid-sim245%3e3.0.co;2-o","journal-title":"Statistics in medicine"},{"issue":"9","key":"4338_CR54","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s11136-013-0380-2","volume":"22","author":"Q Shi","year":"2013","unstructured":"Shi, Q., Mendoza, T. R., Gunn, G. B., Wang, X. S., Rosenthal, D. I., & Cleeland, C. S. (2013). Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 22(9), 2331\u20132339. https:\/\/doi.org\/10.1007\/s11136-013-0380-2","journal-title":"Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation"},{"issue":"1","key":"4338_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.critrevonc.2015.04.011","volume":"96","author":"F De Iuliis","year":"2015","unstructured":"De Iuliis, F., Taglieri, L., Salerno, G., Lanza, R., & Scarpa, S. (2015). Taxane induced neuropathy in patients affected by breast cancer: Literature review. Critical Reviews in Oncology\/Hematology, 96(1), 34\u201345. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.04.011","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"8","key":"4338_CR56","doi-asserted-by":"publisher","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","volume":"17","author":"RA Swarm","year":"2019","unstructured":"Swarm, R. A., Paice, J. A., Anghelescu, D. L., Are, M., Bruce, J. Y., Buga, S., Chwistek, M., Cleeland, C., Craig, D., Gafford, E., Greenlee, H., Hansen, E., Kamal, A. H., Kamdar, M. M., LeGrand, S., Mackey, S., McDowell, M. R., Moryl, N., Nabell, L. M., \u2026 Gurski, L. A. (2019). Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network\u202f: JNCCN, 17(8), 977\u20131007. https:\/\/doi.org\/10.6004\/jnccn.2019.0038","journal-title":"Journal of the National Comprehensive Cancer Network : JNCCN"},{"issue":"12","key":"4338_CR57","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1007\/s00520-019-04771-8","volume":"27","author":"F Yeo","year":"2019","unstructured":"Yeo, F., Ng, C. C., Loh, K. W. J., Molassiotis, A., Cheng, H. L., Au, J. S. K., Leung, K. T., Li, Y. C., Wong, K. H., Suen, L., Chan, C. W., Yorke, J., Farrell, C., Bandla, A., Ang, E., Lopez, V., Sundar, R., & Chan, A. (2019). Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 27(12), 4753\u20134762. https:\/\/doi.org\/10.1007\/s00520-019-04771-8","journal-title":"Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer"},{"key":"4338_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/913848","volume":"2012","author":"CT Pike","year":"2012","unstructured":"Pike, C. T., Birnbaum, H. G., Muehlenbein, C. E., Pohl, G. M., & Natale, R. B. (2012). Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer. Chemotherapy research and practice, 2012, Article 913848. https:\/\/doi.org\/10.1155\/2012\/913848","journal-title":"Chemotherapy research and practice"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04338-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:05:34Z","timestamp":1789643134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-026-04338-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4338"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04338-1","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"247"}}